Does Vaping Affect Blood Work and Test Results?

Understand how vaping can affect your blood work and why disclosing your habits is vital for accurate health assessments.

Vaping can shift several common blood markers, from white blood cell counts and cholesterol levels to platelet activity and kidney function indicators. The size and consistency of those shifts vary by marker, and some are more clinically meaningful than others. What makes the picture complicated is that many studies compare vapers to both nonsmokers and traditional cigarette smokers, and the results do not always land where you would expect. Some markers look worse in vapers than in people who use no nicotine at all, while a few look surprisingly similar to nonsmokers. If you vape and have blood work coming up, the honest answer is that your results could be nudged in ways your doctor might not immediately attribute to an e-cigarette.

White Blood Cells and Immune Response

A complete blood count is one of the most routine panels ordered during a checkup, and one of its key outputs is your white blood cell count. A cross-sectional analysis of U.S. adults using national survey data found that e-cigarette use was associated with higher white blood cells, particularly lymphocytes and monocytes, compared to people who neither smoked nor vaped. That pattern suggests a low-grade systemic immune response. Whether that bump is large enough to push your white blood cell count outside the normal reference range depends on where your baseline sits, but it is the kind of shift that could prompt unnecessary follow-up testing if your doctor does not know you vape.

Inflammatory Markers Are a Mixed Bag

Given the white blood cell findings, you might expect classic inflammation markers like C-reactive protein (CRP) and interleukin-6 to be obviously elevated in vapers. The data so far are more ambiguous. A study of young adult e-cigarette users found no significant difference in high-sensitivity CRP, IL-6, fibrinogen, p-selectin, or myeloperoxidase compared to nonusers after adjusting for age, sex, BMI, and blood pressure. A separate analysis looking at biomarkers like fibrinogen, CRP, and several prostaglandins in e-cigarette users also found nonsignificant changes relative to nonusers.

A larger cross-cohort study added nuance by comparing exclusive e-cigarette users, dual users (vaping and smoking), and former smokers who switched to vaping. Exclusive e-cigarette users showed CRP levels comparable to people who had never smoked. Dual users and former smokers currently using e-cigarettes, on the other hand, had CRP levels similar to exclusive cigarette smokers. The takeaway is that if you are an exclusive vaper who never smoked, your standard inflammation panel may look fairly normal. If you are dual-using or transitioned from cigarettes, your CRP may still be elevated.

Cholesterol, Triglycerides, and Your Lipid Panel

Lipid panels measure total cholesterol, LDL, HDL, and triglycerides, and they are among the blood tests most likely to be affected by vaping. In a large U.S. population analysis, sole e-cigarette users and cigarette smokers both showed higher glucose and triglycerides and lower HDL cholesterol compared to people who never used either product. Dual users had higher triglycerides and very-low-density lipoprotein (VLDL) cholesterol and lower HDL. Interestingly, pod-based device users, both sole and dual, had lipid profiles and glucose levels similar to never users. That last finding hints that the device type or aerosol delivery pattern could matter, though the reasons are not yet well understood.

Animal research adds a wrinkle. In a study of mice chronically exposed to e-cigarette aerosol, male mice showed dramatic increases in total cholesterol, LDL, and triglycerides compared to clean-air controls. Female mice showed a similar directional trend that was not statistically significant. The sex difference is striking and raises questions about whether hormonal factors modulate how vaping affects lipids in humans too. For now, this is animal data and should not be mapped directly onto people, but it suggests the relationship between vaping and cholesterol may not be uniform.

Blood Sugar and Insulin Resistance

If you are getting blood work to monitor diabetes risk, vaping’s effects on glucose and insulin markers are worth knowing about. A national survey-based study found that current e-cigarette use was not associated with prediabetes or diabetes after adjusting for confounders. However, former e-cigarette users were about 22% more likely to show higher insulin resistance compared to people who had never vaped. That is a modest association and could reflect the fact that people who quit vaping may have had heavier use patterns, but it is an interesting signal.

Mouse studies point more directly at nicotine as the culprit. In one experiment, e-cigarette exposure with nicotine-containing liquid significantly decreased insulin tolerance, an effect comparable to traditional cigarette exposure. E-cigarette vapor without nicotine did not impair insulin tolerance. Another mouse study found that nicotine-containing e-vapor improved glucose tolerance in obese mice, which sounds contradictory but likely reflects nicotine’s appetite-suppressing and metabolic-rate-boosting effects in that specific context. In practical terms, if your fasting glucose or HbA1c comes back slightly off, vaping alone probably is not the main driver, but it could be a contributing factor, particularly if you use high-nicotine liquids.

Liver Enzymes

Standard blood panels often include liver enzymes like ALT, AST, GGT, and ALP. A study of e-cigarette users with existing liver disorders and dyslipidemia found that roughly 73% had at least one elevated liver enzyme, with strong positive correlations between triglyceride levels and all four major liver enzymes. This study looked at a population already dealing with liver and lipid problems, so it does not tell us what happens in healthy vapers. But it does suggest that if you already have elevated lipids or liver concerns, vaping could compound the picture and make your liver enzyme readings harder to interpret.

Kidney Function

Creatinine and glomerular filtration rate (GFR) are the standard markers for kidney health. A systematic review examining the effects of vaping on kidney function found that e-cigarette users had elevated serum creatinine levels and a decline in GFR compared to people who did not use nicotine products. The risk of acute kidney injury and the progression of chronic kidney disease were also higher among vapers compared to nonsmokers, though the effects were roughly comparable to those seen in conventional cigarette smokers. So if you switched from smoking to vaping hoping to see your kidney markers improve, the evidence so far is not encouraging on that front.

Platelet Activity and Clotting

One of the more striking findings in vaping research involves platelet function, which standard blood work does not always measure but specialized coagulation panels do. A human study comparing vapers, cigarette smokers, and nonsmokers found that platelet aggregation in response to both collagen and ADP was significantly higher in vapers than in nonsmokers. More surprisingly, collagen-induced aggregation was also significantly higher in vapers than in cigarette smokers. Hyperactive platelets clump together more readily, which raises clotting risk.

Mouse studies reinforce this. Short-term e-cigarette exposure led to hyperactive platelets with enhanced aggregation and granule secretion, shortened clotting times, and resistance to the body’s normal anti-clotting signals. Even thirdhand exposure, residue from e-cigarette aerosol that settles on surfaces, has been shown to enhance platelet aggregation and activation in preclinical models. If you are getting coagulation testing before a surgery or because you take blood thinners, this is information your doctor needs.

Oxidative Stress and Vascular Markers

Some blood panels look beyond basic chemistry at markers of oxidative stress and endothelial function, especially in cardiovascular risk assessments. A study comparing both e-cigarette and traditional cigarette use found that both led to increased markers of oxidative stress (soluble NOX2-derived peptide and 8-iso-prostaglandin F2α), decreased nitric oxide bioavailability, and lower vitamin E levels. Chronic e-cigarette users and smokers showed distinct but overlapping changes in circulating biomarkers of inflammation, clotting, and cell adhesion compared to nonusers. Reduced nitric oxide and elevated oxidative stress markers are associated with stiffer arteries and higher cardiovascular risk over time. These are not markers you will see on a standard metabolic panel, but they do appear in more specialized workups.

Thyroid Hormones

Thyroid panels are common enough that it is worth noting vaping may affect them. A study of male e-cigarette users found increased levels of free T3 and free T4 along with a significant decrease in TSH compared to a control group. That pattern, lower TSH with higher free thyroid hormones, could look like subclinical hyperthyroidism on paper. If your doctor orders a thyroid panel and sees that combination, knowing that you vape could prevent an unnecessary endocrinology referral or imaging workup. This is a single study with a limited population, so the finding needs replication, but it is one of the clearest examples of how vaping could lead to a misdiagnosis if your doctor is not in the loop.

Heavy Metals in Blood and Urine

E-cigarette coils and cartridges contain metals that can leach into the aerosol, leading to concerns about blood lead, cadmium, and other heavy metal levels. The evidence so far is less alarming than you might expect. An analysis of national survey data found that after adjusting for demographic factors, current or former e-cigarette use did not reach statistical significance for associations with blood lead, cadmium, barium, or antimony. People with a combustible smoking history, however, were more likely to have higher blood lead and urinary cadmium. A separate analysis of blood cadmium, lead, and mercury found that concentrations among e-cigarette users were comparable to those among cigarette smokers, with no evidence that e-cigarette users had meaningfully different levels. So while the metals are present in vape aerosol, they do not appear to be accumulating in the blood at levels distinguishable from cigarette smokers on standard panels.

Nicotine and Cotinine Detection

If your blood work involves a nicotine or cotinine screen, vaping will almost certainly trigger a positive result. Cotinine is the primary metabolite your body produces when it breaks down nicotine, and it is the standard biomarker labs use to confirm nicotine exposure. E-cigarette users produce cotinine at levels readily detectable by mass spectrometry, with quantification limits as low as 0.1 ng/mL. This matters for insurance underwriting, pre-employment physicals, and surgical clearance, all of which may use cotinine testing to classify you as a tobacco or nicotine user. Even if you think of vaping as fundamentally different from smoking, the blood test does not distinguish between the two. You will test positive for nicotine exposure.

Propylene Glycol and Lab Assay Interference

There is a less obvious way vaping can mess with your blood work that has nothing to do with what the test is trying to measure. Propylene glycol (PG) is a base liquid in most e-cigarette formulations, and it can interfere with certain lab assays. Specifically, at concentrations approaching 100 mg/dL or higher, propylene glycol caused falsely positive results on an enzymatic ethylene glycol assay. At the lower concentrations expected from normal e-cigarette use (up to about 30 mg/dL in serum), no false positives or interference flags were observed. This means typical vapers are unlikely to trip an ethylene glycol assay, but extremely heavy use or specific clinical circumstances that slow PG clearance could theoretically produce confusing results. If you end up in an emergency room and doctors are running a toxicology panel, propylene glycol from vaping could create a red herring.

Acute Effects Right Before a Blood Draw

Timing matters. Some of vaping’s effects on blood markers are acute, meaning they spike immediately after use and may normalize within hours. A study measuring immediate physiological effects found that subjects who vaped had significantly higher heart rate and breathing frequency, and significantly lower blood oxygen levels, after just 20 minutes. Blood sugar and lung capacity were not significantly affected in that short window. Blood pressure, heart rate, and blood vessel constriction also increase acutely after vaping, comparable to the spike seen after smoking a traditional cigarette. If you vape in the car on the way to a fasting blood draw, you could be introducing short-lived changes in heart rate, blood pressure, and oxygenation that might prompt your doctor to flag something that would not have been there an hour later. The chronic effects described throughout this article are a separate layer on top of that acute response.

Vaping Cannabis Changes the Picture

Not all vaping is the same from a blood work perspective. If you vape CBD or THC liquids instead of or in addition to nicotine, the biological response differs. In a mouse study comparing CBD aerosol inhalation to nicotine aerosol, CBD triggered a significantly greater overall immune cell infiltrate in the lungs. T-cell counts were several-fold higher following CBD inhalation than after nicotine. Serum albumin leaking into lung fluid was also markedly elevated with CBD aerosol compared to both nicotine and clean air. Higher albumin leakage into the lungs could theoretically lower serum albumin on a blood test, and the intense immune activation could produce more pronounced shifts in white blood cell differentials. If you vape cannabis products and your blood work shows unexpected immune or protein markers, the substance you are vaping may matter as much as the act of vaping itself.

Why Your Doctor Needs to Know

The practical problem with all of these findings is that most clinicians are still not routinely asking about e-cigarette use when they order blood work. A case report of a 20-year-old man who developed vaping-associated lung injury and thrombotic coagulopathy highlighted the importance of specifically asking about e-cigarette use in clinical history-taking, since the diagnosis was initially unclear until vaping history was obtained. That is an extreme case, but the principle applies to routine panels too. Elevated white blood cells, abnormal lipids, thyroid values that suggest hyperthyroidism, hyperactive platelets, mildly elevated creatinine: each of these could send your doctor down a diagnostic path that wastes your time and money if the real explanation is sitting in your pocket. When you check in for blood work, mention that you vape, what you vape, and roughly how much. It takes ten seconds and could save you from an unnecessary ultrasound, a repeat panel, or a referral you do not need.